Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Predictive Oncology Q4 EPS $(0.85) Up From $(2.00) YoY, Sales $335.03K Down From $363.47K YoY

Author: Benzinga Newsdesk | March 29, 2024 12:59am
Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.85) per share. This is a 57.5 percent increase over losses of $(2.00) per share from the same period last year. The company reported $335.03 thousand in sales this quarter. This is a 7.82 percent decrease over sales of $363.47 thousand the same period last year.

Posted In: POAI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist